AVBP
ArriVent BioPharmaDNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-22
+
Peers tracked
11
U.S. public peers
Grade Position
Below peers
vs peer average
AVBP vs peer average
38/100
AVBP vs. peer average (D vs. C)
Grade spread
A 2 · B 2 · C 1 · D 3 · F 3
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
ORIC is the first available peer comparator.
ORIC is the closest public small-cap operating comp from the checked primary-source competitor list because ArriVent itself names ORIC among EGFR-mutant NSCLC competitors; it highlights how AVBP is competing in a targeted-oncology setting rather than against generic biotech peers. [#10-K-2026-03-05]
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
AVBP
ArriVent BioPharma
ORIC
Oric
Grade
D
B
Momentum
67
82
Value
41
41
Sentiment
41
-
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Constructive
Grade position vs ORIC
AVBP / ORIC
Grade Position
Below peers
AVBP vs. peer average (D vs. C)
38/100
Momentum
67
ORICValue
41
AVBPSentiment
41
-Rotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs AVBP
ORIC is the first peer returned for this comparison set.